The present study indicates that miR-885-5p suppresses the metastasis of HCC and inhibits Wnt/&#946;-catenin signaling pathway by its CTNNB1 target, which suggests that miR-885-5p to be a promising negative regulator of HCC progression and as a novel therapeutic agent to treat HCC.
C0027627
Neoplasm Metastasis